Stoke Therapeutics
STOK
STOK
96 hedge funds and large institutions have $173M invested in Stoke Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
31% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 36
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
65% less capital invested
Capital invested by funds: $495M → $173M (-$322M)
Holders
96
Holding in Top 10
2
Calls
$283K
Puts
$18K
Top Buyers
| 1 | +$6.74M | |
| 2 | +$1.25M | |
| 3 | +$1.15M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$857K |
| 5 |
D.E. Shaw & Co
New York
|
+$349K |
Top Sellers
| 1 | -$9.15M | |
| 2 | -$3.68M | |
| 3 | -$2.66M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.54M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.19M |